Wave Life Sciences Ltd. - Ordinary Shares (WVE) Covered Calls

You can sell covered calls on Wave Life Sciences Ltd. - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for WVE (prices last updated Fri 4:16 PM ET):

Wave Life Sciences Ltd. - Ordinary Shares (WVE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
13.67 -1.33 12.00 13.67 1.4M - 2.3
Covered Calls For Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 12.5 1.70 11.97 4.4% 44.6%
Jan 17 12.5 2.20 11.47 9.0% 51.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.